Bruker Bioscience, PerkinElmer, Piper Jaffray, Invitrogen, Ciphergen, and Cepheid | GenomeWeb
Bruker’s Revenue, Profits up Sharply in Q3 on Optics Acquisition
 
Bruker Biosciences’ third-quarter revenue increased 22 percent as income jumped by a third, the company said last week.
 
Receipts for the three months ended Sept. 30 rose to $104.8 million from $85.9 million year over year. Product revenues were up 22 percent to $50.1 million and receipts from the company’s services business tallied $8 million, a third more than the same period last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.